A new generation of these medications has transformed treatment possibilities for people who have type 2 diabetes (Ozempic, Mounjaro) or who have obesity or are overweight with a related health condition (Wegovy, Zepbound, Foundayo)
The medications resist being degraded by DPP-4, which is the enzyme that breaks down naturally produced GLP-1 within a few minutes
Can providers continue dispensing GLP-1 medications if a patient doesnt have a clinical diagnosis of diabetes or obesity
For several years, many peptide and chemical suppliers sold GLP-1 compounds such as semaglutide and tirzepatide using labels like Research Use Only (RUO) or Not for Human Consumption . These disclaimers were intended to signal that the products were not meant for patients or consumers
Personalized GLP-1 Responses: Why Genetic Testing Matters The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Its the quality of the medical oversight behind the program